Target intelligence / Profile preview

Neurogranin (protein kinase C substrate) (NRGN)

Target
NRGN
Molecular classification
Protein kinase C substrate, Calmodulin-binding protein, Intrinsically unstructured protein, Postsynaptic signaling protein, member of calpacitin protein family
01

Overview

Neurogranin is an intrinsically unstructured, postsynaptic protein highly expressed in the brain, especially in dendritic spines of pyramidal cells of the hippocampus and cortex[2][3][4]. It binds calmodulin through its IQ motif in a calcium-sensitive manner and is a substrate for protein kinase C, which modulates its association with calmodulin[1][2][4][6]. By regulating calmodulin availability, neurogranin plays a pivotal role in intracellular calcium signaling, synaptic plasticity, long-term potentiation, and thus learning and memory formation. Its gene, NRGN, is controlled in part by thyroid hormones. Clinical investigations highlight neurogranin's altered expression in multiple neuropsychiatric and neurodegenerative diseases, making it a candidate biomarker for disease state and progression[1][2][3][4][5][6]. Although its primary molecular role is as a signaling modulator, neurogranin's concentration in cerebrospinal fluid is being developed as a diagnostic and prognostic tool for synaptic dysfunction and neurodegeneration, especially Alzheimer's disease.

Other names
NeurograninNRGNNgRC3p17hngNEUG(55-78)calmodulin-binding proteinprotein kinase C substrate, RC3BICKS
02

Mechanism of action

For drugs targeting neurogranin (hypothetical/exploratory): - Modulation of neurogranin–calmodulin binding, affecting calcium signaling and synaptic activity - Altering phosphorylation by protein kinase C to influence synaptic strength - Regulation of N-methyl-D-aspartate receptor (NMDAR)-dependent plasticity and signaling

03

Biological functions

Regulation of intracellular calcium signalingModulation of synaptic plasticityRegulation of long-term potentiation (LTP)Synaptic regenerationRegulator of calmodulin availabilitySignal transduction in neurons
04

Disease associations

Neurodegenerative disease (e.g., Alzheimer's disease, Parkinson's disease, Creutzfeldt–Jakob disease)Neuropsychiatric disorders (schizophrenia, depression, bipolar disorder)Brain injury (traumatic brain injury, acute ischemic stroke)Infection-related neurodegeneration (neuro-HIV, neurosyphilis)
05

Safety considerations

Being explored primarily as a biomarker, not a direct drug target—no established therapeutic safety concerns to dateIf considered as a drug target, central nervous system specificity and off-target impact on synaptic signaling would be theoretical challenges
06

Interacting drugs

There are currently no well-validated, clinically used drugs that directly target neurogranin. It is an investigational biomarker rather than a direct drug target at present
07

Biomarkers

Neurogranin concentration in cerebrospinal fluid (CSF): biomarker for synaptic dysfunction and progression in Alzheimer's disease and other neurodegenerative diseasesRatio of CSF neurogranin trunc P75 and beta-secretase BACE1: proposed marker for cognitive decline in Alzheimer's diseaseSerum neurogranin: emerging evidence for use in prognosis and diagnosis of several CNS diseases

Beyond the preview

Go deeper on Neurogranin (protein kinase C substrate) (NRGN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurogranin (protein kinase C substrate) (NRGN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call